Anna Brasher Moreau
About Anna Brasher Moreau
Independent director since 2021 (age 46), Dr. Anna Brasher Moreau is a managing partner at Alexandria Pediatric Dentistry and has practiced pediatric dentistry since 2006. She holds a B.A. in Biology from the University of Texas, a D.D.S. from Baylor College of Dentistry, and earned a Certificate of Pediatric Dentistry and an M.S. after completing a pediatric dental residency at Ohio State University/Columbus Children’s Hospital in 2006; she is a Fellow of the American College of Dentists and a past president of the Louisiana Academy of Pediatric Dentistry and the Central Louisiana Dental Association .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Alexandria Pediatric Dentistry | Managing Partner; Pediatric Dentist | Since 2006 | Practice leadership; clinical expertise |
| Louisiana Academy of Pediatric Dentistry | Past President | — | Professional leadership; industry engagement |
| Central Louisiana Dental Association | Past President | — | Regional professional leadership |
| Rapides Foundation | Past Board Member and Chair | — | Philanthropy; community governance |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| River Oaks Art Center | Board Director | Current | Non-profit arts governance |
| Rapides Foundation | Past Board Member and Chair | Past | Community foundation governance |
Board Governance
- Independence: The Board determined all directors except the CEO are independent; Dr. Moreau is independent under Nasdaq rules. The Nominating & Corporate Governance Committee (of which she is a member) is composed solely of independent directors .
- Committee assignments: Red River Bancshares Nominating & Corporate Governance Committee; Red River Bank Directors’ Loan Committee .
- Chair roles: None indicated for Dr. Moreau; current committee chairs are Teddy R. Price (Compensation; Nominating & Corporate Governance) and H. Lindsey Torbett (Audit) .
- Attendance and engagement: In 2024, the Board met 8 times; independent directors held 4 executive sessions. All incumbent directors attended at least 75% of Board and committee meetings; the Nominating & Corporate Governance Committee met once in 2024 .
- Board leadership: Independent non-executive Chair (Teddy R. Price) presides over executive sessions .
- Risk oversight: Audit oversees financial reporting/internal controls; Compensation monitors compensation risk; Nominating & Corporate Governance reviews related-party transactions and governance .
Fixed Compensation
| Component | 2024 RRBI Director Program Terms | Source |
|---|---|---|
| Annual retainer (cash) | $10,000 | |
| Board meeting fee | $1,500 per board meeting attended | |
| Audit Committee meeting fee (Chair) | $500 per meeting | |
| Audit Committee meeting fee (Member) | $300 per meeting | |
| Other committee meeting fee | $200 per meeting | |
| Equity in lieu of cash | Directors may elect to receive board attendance fees in Company stock; shares issued Jan 31 following year at closing price; committee fees paid in cash only |
| Director | Fees Earned/Paid in Cash (2024) | Fees Paid in Company Stock (2024) | Total (2024) | Notes |
|---|---|---|---|---|
| Anna Brasher Moreau, D.D.S., M.S. | $14,300 | $15,014 | $29,314 | Stock issued Jan 31, 2025 at $55.80 per share closing price |
Performance Compensation
- No performance-based director compensation is disclosed (no options; equity for directors arises only via election to receive board attendance fees in stock). The Company currently does not grant stock options .
Other Directorships & Interlocks
| Company/Organization | Public Company? | Role | Committee Roles | Interlock/Conflict Notes |
|---|---|---|---|---|
| — | — | — | — | No public company directorships disclosed for Dr. Moreau . |
| River Oaks Art Center | No | Board Director | — | Non-profit; no RRBI conflict indicated . |
| Rapides Foundation | No | Past Board Member and Chair | — | Mr. Kirk D. Cooper currently serves on Rapides Foundation’s board, creating a non-profit network tie (historical for Dr. Moreau) . |
Expertise & Qualifications
- Clinical and small-business leadership: Managing partner in a pediatric dental practice since 2006, indicating operational experience and community ties .
- Education/credentials: B.A. Biology (University of Texas), D.D.S. (Baylor College of Dentistry), pediatric dentistry Certificate and M.S. (Ohio State University/Columbus Children’s Hospital); Fellow of the American College of Dentists .
- Community governance: Board roles at River Oaks Art Center; past board member/chair at Rapides Foundation .
Equity Ownership
| Holder | Shares Beneficially Owned | Ownership % of Outstanding | Notes |
|---|---|---|---|
| Anna Brasher Moreau, D.D.S., M.S. | 1,970 | <1% | Includes 865 shares held jointly with spouse |
Additional alignment policies:
- Director nomination stock requirement: Nominees must own Company stock with aggregate book value ≥ $20,000 .
- Insider trading, hedging, and pledging: Prohibits short sales and publicly traded options; hedging strongly discouraged and requires pre-clearance; margin accounts prohibited; pledging requires pre-clearance and demonstrable repayment capacity .
Governance Assessment
- Independence and committee role: Independent director with service on the Nominating & Corporate Governance Committee supports board composition, director selection, and oversight of related-party transactions—positive for governance quality .
- Attendance and engagement: Board met 8 times; all incumbents met at least 75% attendance; she participates in a committee that met in 2024, indicating engagement; independent directors held 4 executive sessions—supports effective oversight .
- Ownership alignment: Direct beneficial ownership of 1,970 shares (<1%); ability to elect stock in lieu of cash for board fees—she elected stock for part of 2024 compensation, signaling alignment with shareholders .
- Conflicts and related-party exposure: Related-party transactions are subject to formal policy and Nominating & Corporate Governance Committee approval; ordinary banking relationships exist broadly but no individual loans or transactions are disclosed for Dr. Moreau—no specific conflicts identified .
- Risk indicators: No disclosures of pledging by Dr. Moreau; hedging restricted by policy; no legal proceedings, SEC investigations, or option repricing disclosed; say-on-pay (for executives) introduced in 2025—no prior vote trend yet .
Overall: Dr. Moreau appears to be an independent, community-anchored director with consistent engagement and modest equity ownership. Her compensation structure (cash retainer/meeting fees with elected stock) and committee membership on Nominating & Corporate Governance suggest alignment and a role in maintaining board effectiveness, with no specific conflicts or red flags disclosed .